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BACKGROUND: Chronic infection with high-risk type of human papillomavirus (HPV) can cause cervical cancer. Previous studies showed that 
multiple infections of HPV are found in cervical cancer 
caused by multiple HPV infections and the most common 
are  HPV-16  and  HPV-52.  The  origin  of  HPV-16 
circulating in Indonesia varies. Purpose of this study was 
to  explore  the  origin  of multiple  infections  of  HPV-52 
and HPV-16 in cervical cancer by using a phylogenetic tree.
METHODS: During July-November 2010, 100 women 
were diagnosed with cervical cancer in the Department 
of Obstetrics and Gynecology, Dr. Hasan Sadikin General 
Hospital, Bandung, Indonesia. Only 96 patients were 
involved in this study. Ninety-six samples of HPV 
deoxyribonucleic acid (DNA) were isolated from biopsied 
tissue of cervical cancer. Multiple infections of HPV 
genotypes HPV-16 and HPV-52 were confirmed by using 
the linear assay for HPV genotyping test. Afterward, HPV-
52 L1 gene was amplified by using self-designed primer. L1 
gene was also sequenced and analyzed using phylogenetic 
program (MEGA6.06).
RESULTS: The result of phylogenetic tree construction 
showed that isolated HPV-52 originated from multiple 
infections of HPV-16 and HPV-52 from cervical cancer 
patients in Bandung were in a subgroup with isolates 
originating from EU077219 Canada (America) and 
KT799980 southwest China (Asia). Isolate HPV-16 in 
one subgroup with isolates originating from KU951191.1 
(Southwest China). 
CONCLUSION: L1 gene sequence from multiple 
infections isolated from HPV-16 and HPV-52 from cervical 
cancer patients in Bandung refers to the variation of L1 gene 
reported from Canada and southwest China. This proves that 
Indonesia’s HPV clusters are located in the strains found in 
America and Asia.
KEywORDS: multiple infections, HPV-16, HPV-52, L1 
gene, phylogenetic
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Abstract
Introduction
Cervical cancer is the second rank of caused-death cancer 
after  breast  cancer  in  woman.  Based  on  the  data  from 
World  Cancer  Statistics,  incidence  of  cervical  cancer 
case  is  estimated  at  528,000  and  266,000  death  cases 
worldwide.(1) An estimated 80% of cervical cancer death 
occurs in developing countries.(2) High prevalence of 
cervical cancer in Indonesia is as many as 11.4%.(3) Totally 
20,928 Indonesian women are diagnosed with cervical 
cancer and 9,498 death caused by  cervical cancer.(4)
 The primary cause of cervical cancer is the human 
papillomavirus (HPV) infection.(1,3) HPV is non-enveloped 
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Methodsdeoxyribonucleic acid (DNA) virus that affects skin or mucosa cells.(5) International consensus divides HPV into 
two groups based on L1 gene sequence. The first group is 
the high-risk genotype, which includes genotypes 16, 18, 
31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 66 that play a role 
in etiology of cervical cancer.(5) While the other group is 
the low-risk genotypes including genotypes 6, 11, 42, 43 
and 44 cause genital warts.(5,6) HPV DNA genomic have 
a double and circular chain of 7,200-8,000 base pairs. HPV 
genomes are divided into three sections. The first region is 
long control region (LCR) which regulates the expression 
and replication; the second region is early protein open 
reading frame (ORF) consisting of E1, E2, E4, E5, E6 and 
E7 that are oncogenic; and the third region is late protein 
encodes which is a protein that plays a role in L1 and L2 
in the formation of the viral capsid.(7) HPV isolates can be 
classified based on the sequences of the L1 genes. According 
to the Nomenclature Committee on Papillomavirus HPV 
genomic is said to have a molecular variant if there is a 
similarity of more than 98% of the prototype L1 gene and 
have different types if the genetic variation is more than 10%. 
HPV with a genetic variation of 2-10% is called subtype, 
while the genetic variation with less than 2% variation is 
called intratype. The L1 gene variations can be analyzed  by 
using phylogenetic tree to determine the origin.(8)
 Based on the previous research in Indonesia, cervical 
cancer is most often caused by infection of HPV-16 HPV-18 
and HPV-52.(9) HPV-52 was found as the cause of cervical 
cancer with the highest prevalence in general population 
with normal cervical examination. Besides HPV-52, 
infection is often found in multiple infections either with 
HPV-16 or HPV-18.(10) The purpose of this research was to 
study the genetic variation of L1 gene by tracing the origin 
of HPV-16 and HPV-52 infections of cervical cancer isolates 
in Bandung by creating a phylogenetic tree. By knowing the 
origin, it is expected to provide information on the use of 
vaccines given as a preventive measure for cervical cancer 
in Indonesia.
Table 1. Primary L1 HPV-16 and HPV-52. 
Research Design
This was a descriptive study. During July-November 2010 
as many as 100 women were diagnosed with cervical cancer 
in the Department of Obstetrics and Gynecology, Dr. Hasan 
Sadikin General Hospital, Bandung. Only 96 patients were 
involved in this study. The inclusion of cervical cancer tissue 
biopsies was performed from patients who subsequently 
had confirmed histopathological diagnoses based on the 
classification of the World Health Organization (WHO). 
General information includes patient’s age, histopathologic 
diagnoses and date of diagnoses were collected from 
patient’s medical records. Out of the 96 patients, there were 
obtained only 54 samples from patients who had consented 
for genotyping examination. Permission to conduct this 
study was given by the Health Research Ethics Committee 
of the Faculty of Medicine, Padjadjaran University, Bandung 
No. 874/UN6. C1.3.2/KEPK/PN/2016.
Amplification of HPV-16 and HPV-52 L1 Gene
HPV-16 and HPV-52 were amplified by PCR using primers 
based on sequence provided by Genebank of www.ncbi.nlm.
nih.gov to obtain fragments of L1 gene HPV-16 and HPV-52 
(Table 1). The process of PCR for HPV-16 L1 was performed 
at the denaturation temperature of 95oC for 30 seconds, 
the temperature amplification 51.1oC for 30 seconds (40 
cycles), and extension temperature 72oC for 1 minute 30 
seconds and 72oC for 5 minutes. While the process of PCR 
for HPV-52 L1 was carried out at a temperature of 95oC for 
3 minutes, cycles of denaturation at a temperature of 95oC 
for 30 seconds, the temperature amplification 48oC for 30 
seconds (35 cycles), and the temperature extension 72oC for 
1 minute 30 second and 72oC for 5 minutes. PCR results 
were obtained from imaging process of electrophoresis on 
agarose gel 1% with a voltage of 100 volt 400 mA current 
for 30 minutes. PCR results then were processed through 
L1 HPV Annealing Length of PCR Product Primer
L1 HPV-52 48⁰C 1500bp Forward 5’-TGG TAC AGA TTT TAT TTT ACA TCC-3’
Reverse 5’-TTA CCT TTT AAC CTT TTT CTT CT-3’
L1 HPV-16 51.1⁰C 1500bp Forward 5’-CAA TTA TTG CTG ATG CAG GTG ACT-3’
Reverse 5’-CTT ACA GCT TAC GTT TTT TGC G-3’
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Results
The sample used in this study came from patients who had 
been diagnosed with cervical cancer in the Department of 
Obstetrics and Gynecology, Dr. Hasan Sadikin General 
Hospital Bandung with degree IIA/IIB FIGO classification 
based on the histopathology type of Squamous Cell 
Carcinoma (SCC).(10) The cervical cancer tissue biopsy 
then underwent DNA isolation and confirmation of design 
creation by using data Genebank www.ncbi.nlm.nih.gov 
with access numbers obtained EU077226 primary HPV-52 
L1  two primers (Table 1). The results of amplification using 
forward and reverse primer obtained fragments of HPV-52 
L1 throughout 1500 bp (Figure 1), while the HPV-16 L1 
amplification used a primer pre-existing (Table 1). The 
results of amplification using forward and reverse primer 
obtained fragments of HPV-16 L1 throughout 1500 bp 
(Figure 2). The results sequences processed using software 
ClustalX 2.1. and MEGA6.06. The results of phylogenetic 
analysis showed that the isolated DNA of HPV in Bandung 
has a kinship with those in EU077219 Canada (America) 
and KT799980, KU951191.1 Southwest China (Asia).
sequencing performed at 1st BASE DNA sequencing (Kuala 
Lumpur, Malaysia) to obtain the sequence of the gene 
sequence of nitrogenous bases L1 HPV-16 and HPV-52.
Data Analysis
The data were analyzed using sequences Bioedit software 
(version 7.2.5.0), nucleotide BLAST, and ClustalX 2.1. 
Making the phylogenetic tree was done by using software 
MEGA 6.06 (11) and the HPV-16 and HPV-52 relationship 
was analyzed by comparing sequences of the base sequence 
of nitrogen from L1 gene HPV-16 and HPV-52 isolates of 
patients with cervical cancer in Bandung with those in other 
countries. 
Figure 1. Electrophoresis 
HPV-52 L1 gene results for 
Polymerase Chain Reaction. 
The results of amplification 
using forward and reverse primer 
obtained fragments of HPV-52 L1 
throughout 1500 bp.
Figure 2. Electrophoresis HPV-16 L1 
gene results for Polymerase Chain 
Reaction. The results of amplification 
using forward and reverse primer 
were obtained fragments of HPV-16 
L1 throughout 1500 bp.
Discussion
The most often HPV genotypes which infect cervical cancer 
patients in Indonesia were HPV-16, followed by HPV-18, 
and HPV-52.(3) The distribution of HPV in various regions 
of the world is different. Based on the analysis of sequences 
of L1 HPV variants are distinguished in five phylogenetic 
clusters which are European (E), Asia (As), Asian American 
(AA), Africa 1 (AF1), and Africa 2 (AF2).(12) Variations 
on each HPV have a risk of carcinogenic effects, such as 
variation of HPV-16 has a high-risk carcinogenic effect in 
Asian-American and African variants rather than European 
variants. While the HPV-52 variations have risk of 
carcinogenic in Asia and European variants.(13)
 In the phylogenetic tree, nitrogenous bases isolate 
HPV-52 Bandung has bootstrap 66% (Figure 3). This is 
a method to evaluate the feasibility of phylogenetic trees. 
Bootstrap above 50% indicates acceptable phylogenetic 
tree. Isolate HPV-52 Bandung was located in the same 
cluster with Canada (America), Southwest China (Asia), 
HongKong (Asia), Japan (Asia), China (Asia) and the 
USA, but different clusters to isolate Canada EU077226. 
The access number is used as a reference sequence of the 
primary manufacture. Each cluster is divided into groups and 
subgroups. The first cluster, isolate Canada shows separated 
from isolate China. Isolate HPV-52 of cervical cancer 
patients in Bandung (Indonesia) were in a subgroup with 
the isolates originating from EU077219 Canada (America) 
and KT799980 Southwest China (Asia). Thus it can be 
concluded that the Bandung isolate has a closer kinship 
with isolates originating from Canada and Southwest China 
compared with isolates originating from HongKong, Japan, 
and the USA. 
 Based on the search results, the origin of HPV-16 
L1 of the DNA isolate infecting patients the HPV-16 and 
HPV-52 were in the same cluster with isolate HQ644246.1 
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Figure 3. Phylogenetic tree of HPV 52 L1 
Nitrogen Bases with Neighboor-Joining 
method Pylogenetic Tree MEGA 6.06.
(11) Isolate HPV-52 Bandung was located 
in the same cluster with Canada (America), 
Southwest China (Asia), HongKong 
(Asia), Japan (Asia), China (Asia), and 
the USA , and different clusters to isolate 
Canada EU077226 access number are used 
as a reference sequence of the primary 
manufacture.
Figure 4. Phylogenetic tree of HPV 16 L1 
Nitrogen Bases with Neighboor-Joining 
method Pylogenetic Tree MEGA 6.06.
(11) The search results the origin of HPV-
16 L1 of the DNA isolate infecting patients 
the HPV-16 and HPV-52 were on one 
cluster with islolat HQ644246.1 (USA), and 
EU430680.1 (China) as well as being in one 
subgroup isolates KU951191.1 (Southwest 
China).
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(USA), and EU430680.1 (China). It also and has bootstrap 
70% (Figure 4) with isolates KU951191.1 as well as being 
in one subgroup isolates KU951191.1 (Southwest China). 
These  results indicate that the majority of isolates of 
patients with cervical cancer in Bandung contained in one 
cluster to the origin isolate of other Asian countries. This 
is consistent with previous studies conducted in Bandung 
by Fadhilah with HPV-16 isolates that have origins kinship 
with isolates from Asia and East Asia (14) and the research 
conducted by Suhandono on isolate single HPV-52 infection 
that has real origin  kinship  with  the  isolates  from  the 
Philippines (Asia).(15)
 This shows that there are certain types of HPV 
genomes that were clustered according to the ethnic people 
and regions where they are isolated. It has been shown by 
HPV-16 and represents the lineage of HPV variants are 
genetically inherited.(12) The types of HPV that mostly 
infect women in Asia are HPV -16 (2.5%), HPV-18 (1.4%), 
and HPV-52 (0.7%).(16) The distribution of HPV types 
is based on the proximity of the geographical location, 
ethnically, and lifestyle of the individual.(17)
 From the results of this study, the isolates in Bandung 
HPV L1 genes have origins kinship with isolates from 
EU077219 Canada and KT799980, KU951191.1 Southwest 
China.  It  is  based  on the characteristic of L1 isolate 
genes in Bandung which is similar to the ones in Canada 
(America) and Southwest China (Asia), compared to other 
isolates.
 Limitation of this study is the result of sequence HPV-
52 and HPV-16 is not full length resulting in a slight variation 
of kinship between HPV-52 and HPV-16 in Indonesia and 
other countries. 
Conclusion
HPV-L1 gene sequence of HPV-16 and HPV-52 isolates 
from multiple infections of HPV-16 and HPV-52 in cervical 
cancer  patients  in  Bandung  refers  to  the L1 gene 
variation in Canada and Southwest China. This proves that 
Indonesia’s HPV clusters are found in the strains of America 
and Asia.
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